These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

319 related items for PubMed ID: 18827052

  • 21. Immunogenic oxidized low-density lipoprotein/beta2-glycoprotein I complexes in the diagnostic management of atherosclerosis.
    Lopez LR, Kobayashi K, Matsunami Y, Matsuura E.
    Clin Rev Allergy Immunol; 2009 Aug; 37(1):12-9. PubMed ID: 18982458
    [Abstract] [Full Text] [Related]

  • 22. Subclinical atherosclerosis in systemic lupus erythematosus and antiphospholipid syndrome: focus on β2GPI-specific T cell response.
    Conti F, Spinelli FR, Alessandri C, Pacelli M, Ceccarelli F, Marocchi E, Montali A, Capozzi A, Buttari B, Profumo E, Sorice M, Arca M, Valesini G, Riganò R.
    Arterioscler Thromb Vasc Biol; 2014 Mar; 34(3):661-8. PubMed ID: 24436371
    [Abstract] [Full Text] [Related]

  • 23. Systemic lupus erythematosus, atherosclerosis, and autoantibodies.
    Zampieri S, Iaccarino L, Ghirardello A, Tarricone E, Arienti S, Sarzi-Puttini P, Gambari P, Doria A.
    Ann N Y Acad Sci; 2005 Jun; 1051():351-61. PubMed ID: 16126977
    [Abstract] [Full Text] [Related]

  • 24. IgG autoantibodies against beta2-glycoprotein I complexed with a lipid ligand derived from oxidized low-density lipoprotein are associated with arterial thrombosis in antiphospholipid syndrome.
    Lopez D, Kobayashi K, Merrill JT, Matsuura E, Lopez LR.
    Clin Dev Immunol; 2003 Jun; 10(2-4):203-11. PubMed ID: 14768953
    [Abstract] [Full Text] [Related]

  • 25. OxLDL/beta2GPI-anti-oxLDL/beta2GPI complex and atherosclerosis in SLE patients.
    Bassi N, Ghirardello A, Iaccarino L, Zampieri S, Rampudda ME, Atzeni F, Sarzi-Puttini P, Shoenfeld Y, Doria A.
    Autoimmun Rev; 2007 Nov; 7(1):52-58. PubMed ID: 17967726
    [Abstract] [Full Text] [Related]

  • 26. Accelerated atherosclerosis, immune response and autoimmune rheumatic diseases.
    Jara LJ, Medina G, Vera-Lastra O, Amigo MC.
    Autoimmun Rev; 2006 Mar; 5(3):195-201. PubMed ID: 16483919
    [Abstract] [Full Text] [Related]

  • 27. [Oxidatively modified lipoproteins and their antibodies in patients with antiphospholipid syndromeand systemic lupus erythematosus].
    Roch B, Kopprasch S, Pietzsch J, Schröder HE.
    Z Rheumatol; 2004 Aug; 63(4):331-7. PubMed ID: 15338257
    [Abstract] [Full Text] [Related]

  • 28. oxLDL/β2GPI/anti-β2GPI complex induced macrophage differentiation to foam cell involving TLR4/NF-kappa B signal transduction pathway.
    Xu Y, Kong X, Zhou H, Zhang X, Liu J, Yan J, Xie H, Xie Y.
    Thromb Res; 2014 Aug; 134(2):384-92. PubMed ID: 24882274
    [Abstract] [Full Text] [Related]

  • 29. Proatherogenic oxidized low-density lipoprotein/β2-glycoprotein I complexes in arterial and venous disease.
    Berger JS, Rockman CB, Guyer KE, Lopez LR.
    J Immunol Res; 2014 Aug; 2014():234316. PubMed ID: 25405208
    [Abstract] [Full Text] [Related]

  • 30. Accelerated atheroma in the antiphospholipid syndrome.
    Matsuura E, Kobayashi K, Tabuchi M, Lopez LR.
    Rheum Dis Clin North Am; 2006 Aug; 32(3):537-51. PubMed ID: 16880083
    [Abstract] [Full Text] [Related]

  • 31. Involvement of TLR4 in oxidized LDL/β2GPI/anti-β2GPI-induced transformation of macrophages to foam cells.
    Zhang X, Xie Y, Zhou H, Xu Y, Liu J, Xie H, Yan J.
    J Atheroscler Thromb; 2014 Aug; 21(11):1140-51. PubMed ID: 24998486
    [Abstract] [Full Text] [Related]

  • 32. Beta2-glycoprotein I: antiphospholipid syndrome and T-cell reactivity.
    Kuwana M.
    Thromb Res; 2004 Aug; 114(5-6):347-55. PubMed ID: 15507264
    [Abstract] [Full Text] [Related]

  • 33. Oxidized-LDL/beta(2)-glycoprotein I complexes are associated with disease severity and increased risk for adverse outcomes in patients with acute coronary syndromes.
    Greco TP, Conti-Kelly AM, Anthony JR, Greco T, Doyle R, Boisen M, Kojima K, Matsuura E, Lopez LR.
    Am J Clin Pathol; 2010 May; 133(5):737-43. PubMed ID: 20395520
    [Abstract] [Full Text] [Related]

  • 34. Platelets and the antiphospholipid syndrome.
    Urbanus RT, Derksen RH, de Groot PG.
    Lupus; 2008 Oct; 17(10):888-94. PubMed ID: 18827053
    [Abstract] [Full Text] [Related]

  • 35. Antibodies to oxidized low density lipoprotein: epidemiological studies and potential clinical applications in cardiovascular disease.
    Gounopoulos P, Merki E, Hansen LF, Choi SH, Tsimikas S.
    Minerva Cardioangiol; 2007 Dec; 55(6):821-37. PubMed ID: 18091649
    [Abstract] [Full Text] [Related]

  • 36. Atherosclerosis-related markers in systemic lupus erythematosus patients: the role of humoral immunity in enhanced atherogenesis.
    George J, Harats D, Gilburd B, Levy Y, Langevitz P, Shoenfeld Y.
    Lupus; 1999 Dec; 8(3):220-6. PubMed ID: 10342715
    [Abstract] [Full Text] [Related]

  • 37. Libman-Sacks endocarditis associated with antiphospholipid syndrome and infection.
    Blank M, Shani A, Goldberg I, Kopolovic J, Amigo MC, Magrini L, Shoenfeld Y.
    Thromb Res; 2004 Dec; 114(5-6):589-92. PubMed ID: 15507295
    [Abstract] [Full Text] [Related]

  • 38. [OxLDL/β2-glycoprotein I complex as a pro-atherogenic autoantigen. Is atherosclerosis an autoimmune disease?].
    Kraml P.
    Vnitr Lek; 2016 Dec; 62(11 Suppl 4):S48-51. PubMed ID: 27921425
    [Abstract] [Full Text] [Related]

  • 39. Prevalence of antiphospholipid and antioxidized low-density lipoprotein antibodies in rheumatoid arthritis.
    Sherer Y, Gerli R, Vaudo G, Schillaci G, Gilburd B, Giordano A, Bocci EB, Allegrucci R, Marchesi S, Mannarino E, Shoenfeld Y.
    Ann N Y Acad Sci; 2005 Jun; 1051():299-303. PubMed ID: 16126971
    [Abstract] [Full Text] [Related]

  • 40. β2-glycoprotein I and oxidative inflammation in early atherogenesis: a progression from innate to adaptive immunity?
    Matsuura E, Lopez LR, Shoenfeld Y, Ames PR.
    Autoimmun Rev; 2012 Dec; 12(2):241-9. PubMed ID: 22569463
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.